Fundraising Fox

Hillhouse Investment

Private equity

Singapore · Growth–Late Stage

Also known as HHLR ADVISORS, LTD. · Hillhouse Capital Management, Ltd. · Hillhouse Japan Pte. Ltd.

Fox Verdict
Sign up to see your fit

Investment thesis

Hillhouse Investment applies a disciplined, research-driven, long-term investment approach grounded in alignment, quality, and sustainability. With nearly two decades of experience, the firm partners with exceptional management teams to help businesses build resilient franchises and adapt to changing needs. It emphasizes business fundamentals, industry insight, patience, and commercial acumen to identify emerging trends and anticipate future needs. Hillhouse invests globally across healthcare, industrials, energy transition, business services, and consumer opportunities, aiming to back companies that can endure and drive sustainable positive change while creating lasting value for all stakeholders.

Source: firm website, verified Aug 18, 2026.

Stage
Growth–Late Stage
HQ
Singapore, HK
Instruments
Equity
Founded
2005
Last 12 months
2 investments
Private fund assets
$59B
Tracked investments
3

What they invest in

from 3 of 3 portfolio companies

Biotech ×2Medical Devices ×2Deep Tech ×1FoodTech ×1Retail Tech ×1SaaS ×1

HQs:United States×2Japan×1

Investments · 3 tracked

founders shown can be your intro path
Axoftaxoft.usinApr 2026 · $55M

Axoft develops implantable neural interfaces that communicate bidirectionally with the brain, combining materials science, electronics, and artificial intelligence.

BiotechDeep TechMedical DevicesCambridge, US

Paul Le Floch(Executive Officer, Director)inTianyang Ye(Director)Rachel Sha(Director)

BoardChia An Lee(Director)Benjamin Pless(Director)

Co-investorsArcherman CapitalBlindspot Ventures Management CoCastor Ventures (an Alumni Ventures Fund)Creative Destruction Lab (CDL)Safar PartnersThe Engine Ventures+2 more

Third Arc Biothirdarcbio.cominFeb 2026

Third Arc Bio develops breakthrough treatments in oncology and immunology through advanced biologics engineering.

BiotechMedical DevicesLower Gwynedd, US

Joseph Erhardt(Executive Officer)Peter Lebowitz(Executive Officer, Director)

BoardArjun Goyal(Director)inOtello Stampacchia(Director)Francesco Draetta(Director)in

Co-investorsAndreessen HorowitzVida Venturesabrdn plcBiotechnology Value FundForesite CapitalOmega Funds+1 more

株式会社ダイニーdinii.jp

Dinii offers an all-in-one restaurant cloud that combines POS, mobile ordering, CRM, staff attendance, payments, reservations, and management analytics for restaurants.

FoodTechRetail TechSaaSTokyo, JP

Mao Yamada(Founder)in

Co-investorsBessemer Venture PartnersCoral CapitalGlobis Capital Partners

Portfolio news

latest coverage across their companies

Public market activity · per SEC filings

what is this? ⓘ
Cytek Biosciences, Inc.SC 13G

Disclosed stake · filed Nov 2024

view filing ↗
Sagimet Biosciences Inc.SC 13G/A

Disclosed stake · filed Nov 2024

view filing ↗
Hesai GroupSC 13G/A

Disclosed stake · filed Mar 2024

view filing ↗
Legend Biotech CorpSC 13G/A

Disclosed stake · filed Feb 2024

view filing ↗
Gossamer Bio, Inc.SC 13G/A

Disclosed stake · filed Feb 2024

view filing ↗
China Jo-Jo Drugstores Holdings, Inc.SC 13D/A

Disclosed stake · filed Feb 2023

view filing ↗
TScan Therapeutics, Inc.SC 13G/A

Disclosed stake · filed Feb 2023

view filing ↗
SC 13G/A filingSC 13G/A

Disclosed stake · filed Feb 2022

view filing ↗
SC 13G filingSC 13G

Disclosed stake · filed Feb 2022

view filing ↗
SC 13G filingSC 13G

Disclosed stake · filed Feb 2022

view filing ↗
SC 13D/A filingSC 13D/A

Disclosed stake · filed Jul 2021

view filing ↗
SC 13G filingSC 13G

Disclosed stake · filed Jul 2021

view filing ↗

16 insider ownership filings (Forms 3/4/5)

at ArriVent BioPharma, Inc. (AVBP), BeiGene, Ltd. (BGNE), ArriVent Biopharma, Inc. (AVBP)

Files 13F institutional holdings reports · latest Aug 2019

From the firm's own SEC EDGAR filings — stakes and insider roles in public companies, typically portfolio companies after an IPO. Not a portfolio list published by the firm.

Frequently asked questions

What stage does Hillhouse Investment invest at?
Hillhouse Investment invests at the Growth, Late Stage stages.
What sectors does Hillhouse Investment focus on?
Hillhouse Investment focuses on Advanced Manufacturing, Climate Tech, Consumer, Energy, Enterprise Software, Healthtech, Sector Agnostic.
Where is Hillhouse Investment located?
Hillhouse Investment is headquartered in Singapore, HK.

Similar investors

Featured in lists